Other
Respiratory Infections
0
Pipeline Programs↗
4
Active Trials↗
0
Companies Involved↗
Respiratory Infections is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
14
clinical trials
Completed7 · 50%
Active, not recruiting2 · 14%
Unknown status2 · 14%
Not yet recruiting1 · 7%
Terminated1 · 7%
Recruiting1 · 7%
Clinical Trials
Trial Activity
14 trials
OM 85 to Prevent Respiratory Infections in Older At Risk Patients
Recruiting·—·Phase 4·NCT06655272·360 enrolled
OM 85 to Prevent Respiratory Infections in Older At Risk Patients
Active, not recruiting·FFondazione Policlinico Universitario Campus Bio-Medico·Phase 4·NCT07178002·360 enrolled
Role of Zinc in Recurrent Acute Lower Respiratory Infections
Completed·—·Phase 3·NCT00536133·208 enrolled
Comparative Effectiveness of Antibiotics for Respiratory Infections
Completed·—·N/A·NCT02297815·2,472 enrolled
Effectiveness and Safety of the of Guaifenesin, Doxylamine Succinate and Hydrochloride Etafedrine Syrup in Improvement of Symptoms Resulting From Acute Respiratory Infections.
Unknown status·—·Phase 3·NCT00857987·174 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)